Clinical study of a surviving long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma

Robert A. Fenstermaker; Michael J. Ciesielski; Jingxin Qiu; Nuo Yang; Nuo Yang; Cheryl L. Frank; Kelvin P. Lee; Laszlo R. Mechtler; Ahmed Belal; Manmeet S. Ahluwalia; Alan D. Hutson

doi:10.1007/S00262-016-1890-X

Clinical study of a surviving long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma

Robert A. Fenstermaker, Michael J. Ciesielski, Jingxin Qiu, Nuo Yang, Nuo Yang, Cheryl L. Frank, Kelvin P. Lee, Laszlo R. Mechtler, Ahmed Belal, Manmeet S. Ahluwalia, Alan D. Hutson

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer Immunology, Immunotherapy
Volume	65
DOIs	https://doi.org/10.1007/S00262-016-1890-X
State	Published - Aug 30 2016

Disciplines

Medicine and Health Sciences
Oncology

Access to Document

10.1007/S00262-016-1890-XLicense: Unspecified

Cite this

@article{d1bf140b9c194e19b7f84b20789601a7,

title = "Clinical study of a surviving long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma",

author = "Fenstermaker, \{Robert A.\} and Ciesielski, \{Michael J.\} and Jingxin Qiu and Nuo Yang and Nuo Yang and Frank, \{Cheryl L.\} and Lee, \{Kelvin P.\} and Mechtler, \{Laszlo R.\} and Ahmed Belal and Ahluwalia, \{Manmeet S.\} and Hutson, \{Alan D.\}",

year = "2016",

month = aug,

day = "30",

doi = "10.1007/S00262-016-1890-X",

language = "American English",

volume = "65",

journal = "Cancer Immunology, Immunotherapy",

}

TY - JOUR

T1 - Clinical study of a surviving long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma

AU - Fenstermaker, Robert A.

AU - Ciesielski, Michael J.

AU - Qiu, Jingxin

AU - Yang, Nuo

AU - Frank, Cheryl L.

AU - Lee, Kelvin P.

AU - Mechtler, Laszlo R.

AU - Belal, Ahmed

AU - Ahluwalia, Manmeet S.

AU - Hutson, Alan D.

PY - 2016/8/30

Y1 - 2016/8/30

UR - https://link.springer.com/content/pdf/10.1007%2Fs00262-016-1890-x.pdf

U2 - 10.1007/S00262-016-1890-X

DO - 10.1007/S00262-016-1890-X

M3 - Article

VL - 65

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

ER -

Clinical study of a surviving long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma

Disciplines

Access to Document

Other files and links

Cite this